Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Tigaraksa Satria Tbk. (TGKA)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Tigaraksa Satria Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Tigaraksa Satria Tbk. diperdagangkan di Rp4.970 (kapitalisasi pasar 4,56 T, volume 24 jam 300). Perbedaan utamanya: Tigaraksa Satria Tbk. jauh lebih besar — sekitar 43,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TGKA | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 4,56 T |
Volume | — | 300 |
Lot | — | 3 |
Perputaran | — | 1,5 jt |
Harga Rata-rata | — | 5.015 |
Nilai Transaksi | — | 1,5 jt |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Tigaraksa Satria Tbk.
PT Tigaraksa Satria Tbk (the Company) was established in Jakarta based on notarial deed No. 35 of M.M.I. Wiardi, S.H., dated November 17, 1986. PT. Tigaraksa Satria is a distributor of Nutrition, Chemicals, Cosmetic, Books, Garments and other consumer goods. Founded in 1987 as a subsidiary of PT. Tigaraksa, the company handles the dosmetic distribution products for more than 20 pricipals.
Selengkapnya di halaman TGKA →
